Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / U.S. PHARMA ETF
-
Number of holders
-
107
-
Total 13F shares, excl. options
-
521,386
-
Shares change
-
-20,966
-
Total reported value, excl. options
-
$104,202,203
-
Value change
-
-$3,381,738
-
Number of buys
-
37
-
Number of sells
-
-38
-
Price
-
$199.66
Significant Holders of ISHARES TR - U.S. PHARMA ETF (IHE) as of Q4 2021
121 filings reported holding IHE - ISHARES TR - U.S. PHARMA ETF as of Q4 2021.
ISHARES TR - U.S. PHARMA ETF (IHE) has 107 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 521,386 shares
.
Largest 10 shareholders include WELLS FARGO & COMPANY/MN (59,871 shares), MORGAN STANLEY (47,996 shares), ROYAL BANK OF CANADA (42,458 shares), BROWN ADVISORY INC (37,346 shares), BANK OF AMERICA CORP /DE/ (33,748 shares), RAYMOND JAMES & ASSOCIATES (31,446 shares), LPL Financial LLC (24,310 shares), MURPHY CAPITAL MANAGEMENT INC (18,075 shares), Steward Partners Investment Advisory, LLC (16,728 shares), and COMMONWEALTH EQUITY SERVICES, LLC (13,546 shares).
This table shows the top 107 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.